Ten63 Therapeutics is pushing the boundaries of computationally designed drugs to better target diseases. 🎯 DIBS member Bruce Donald and his @dukebiochem / @dukecompsci co-founders are making rapid progress on the start-up. https://t.co/OALBn7Zbbm
Register for our Chordoma Foundation Labs webinar on September 20! And bring your questions about chordoma research: Our lab director Dan Freed, PhD, will host a live audience Q&A after his talk.
https://t.co/89PA0Pqi31
Congrats to graduate @Jellatech1. Focused on the development of cell-based human collagen, which has applications for arthritis treatment, regenerative medicine, and much more.
Today we announced a $150M Series B financing, enabling the advancement of our lead program to clinical proof-of-mechanism and marking an important transition for our company. Read today’s news: https://t.co/elb17WzB65
Apply to @OtsukaUS’s Golden Ticket competition for a chance to win free lab bench space at any @biolabs US location! Application period open now through July 21:
https://t.co/RHPfGbuYDC
Calling all biotech entrepreneurs! Don’t miss the chance to win free lab space and membership at @biolabs through @OtsukaUS’s Golden Ticket competition.
Apply by July 21st using this link: https://t.co/RHPfGbuYDC
BioLabs sponsor @ChiesiGRD’s Golden Ticket competition is live! Gain access to free lab space and membership at a @biolabs US location of your choice.
Apply by September 22nd: https://t.co/5JuES7m4xt
🔬We're hiring a Research Technician at Chordoma Foundation Labs in Durham, NC! We're seeking a talented individual who'll help us uncover new therapeutic strategies for chordoma. Check out the opening and spread the word. @sommerjo@BioLabsNC https://t.co/46Zv70y5gX
Great testimonial of how @biolabs helps advance #science:
After joining @BioLabsNC, the @ChordomaFDN was able to increase their work driving research projects forward, increasing from 1 to 4 the number of clinical projects launched per year.
Thank you Dr. Dan Freed !
BREAKING: @Cereius, a @DukeU radiotherapeutics #startup co-founded by @DukeMedSchool Prof Michael Zalutsky and Dr. @KimLBlackwell, has been acquired by Solve Therapeutics. The company is also investing in research facilities at @BioLabsNC in #Durham. https://t.co/C7n4Zrbwa5
Ten63 Therapeutics raises $15.9 million Series A to use generative AI to make small molecule drugs for undruggable proteins, including cancer-linked protein Myc. My story for @endpts - https://t.co/Cx5K8a43V1
Are you interested in #biotech in #NorthCarolina? @LaunchBio is partnering with @BioLabsNC to do a review of the local industry on 5/4. @DukeU@DukeOTC start-ups @Cereius and Isolere Bio will be spotlighted! More info and registration link here: https://t.co/r3CjLNoiGT
Learn how Lee, our newest bench scientist at Chordoma Foundation Labs, is unlocking new possibilities for chordoma treatment development: https://t.co/VGLbZZhCLG
CED is happy to welcome @BioLabsNC as a display sponsor for #VentureConnect2023! BioLabs is a provider of flexible lab space for biotech startups in the United States and Europe and has been a multi-year supporter of the Venture Connect conference.
Combined, Duke and UNC received more than $1.2B in funding from the National Institutes of Health in 2022, among the highest levels in the nation. https://t.co/S1hKBIty1F
The Gro Incubator hosted by @CEDNC application is now open. Cohort companies will network with skilled entrepreneurs and coaches while taking weekly classes to help launch their ventures.
Apply here: https://t.co/EGqqa4fHgb